MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 238 filers reported holding MYRIAD GENETICS INC in Q1 2017. The put-call ratio across all filers is 2.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $358,000 | -71.9% | 11,760 | -81.8% | 0.03% | -69.8% |
| Q4 2020 | $1,275,000 | -22.1% | 64,474 | -48.6% | 0.09% | -20.4% |
| Q3 2020 | $1,636,000 | -80.7% | 125,449 | -61.8% | 0.11% | -68.3% |
| Q2 2017 | $8,481,000 | +129.1% | 328,200 | +47.8% | 0.34% | +40.3% |
| Q4 2016 | $3,702,000 | +5.5% | 222,056 | +30.2% | 0.24% | +18.5% |
| Q3 2016 | $3,509,000 | -17.8% | 170,500 | +22.2% | 0.20% | -39.3% |
| Q2 2016 | $4,269,000 | -18.2% | 139,500 | 0.0% | 0.34% | +3.4% |
| Q1 2016 | $5,221,000 | +50.9% | 139,500 | +73.9% | 0.33% | -31.0% |
| Q4 2015 | $3,461,000 | +27.7% | 80,200 | +10.9% | 0.47% | +677.0% |
| Q3 2015 | $2,710,000 | +63.9% | 72,314 | +48.7% | 0.06% | +41.9% |
| Q2 2015 | $1,653,000 | +51.9% | 48,642 | +72.4% | 0.04% | +53.6% |
| Q3 2014 | $1,088,000 | -11.7% | 28,214 | -10.8% | 0.03% | -15.2% |
| Q2 2014 | $1,232,000 | +4.3% | 31,642 | -8.4% | 0.03% | +17.9% |
| Q1 2014 | $1,181,000 | -88.3% | 34,556 | -92.0% | 0.03% | -89.8% |
| Q3 2013 | $10,122,000 | +121.1% | 430,743 | +152.8% | 0.27% | +132.2% |
| Q2 2013 | $4,578,000 | – | 170,373 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |